Winlevi

Chemical Nameclascoterone
Dosage FormCream (topical; 1% )
Drug ClassInhibitors
SystemSkin
CompanyCassiopea Inc.
Approval Year2020

Indication

  • To treat acne vulgaris in patients 12 years and older.
Last updated on 12/9/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Winlevi (clascoterone) Prescribing Information. 2020Cassiopea Inc, Milan, Italy